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Background Pulmonary vein isolation (PVI) is becoming the therapy of choice for symptomatic paroxysmal drug-refractory atrial fib-
rillation (AF). The most frequently reported complications are vascular complications (1.4%). Bleeding complications of
the central nervous system have rarely been described. We report a case of spontaneous spinal bleed after PVI.
...................................................................................................................................................................................................
Case summary A 68-year-old woman with a 2-year history of highly symptomatic paroxysmal AF (EHRA 3) was referred for a PVI
redo procedure. A high-density mapping showed pulmonary vein reconnection of all pulmonary veins successfully
isolated by radiofrequency ablation. During the entire procedure, the patient had sinus rhythm with an ACT
around 300 s. No intraprocedural and peri-procedural complications occurred. Four hours after haemostasis, the
anticoagulation clotting time (ACT) was 110 s and rivaroxaban (20 mg) was reinitiated. In the following hours, the
patient developed fluctuating neurological lower limb symptoms. A lumbar magnetic resonance imaging showed a
subdural spinal haematic collection with an associated epidural component from L3 to S2 exerting compression
over the dural sheath. A conservative treatment approach was adopted with progressive recovery of sensorial and
motor deficits. After 5 months, the patient still presented residual lower limb motor deficits necessitating the sup-
port of a walking stick.
...................................................................................................................................................................................................
Discussion We describe the first case of a spontaneous spinal bleeding following PVI. Given the gradual diffusion of PVI to
treat AF in more clinically complex patients with a larger range of comorbidities, particular consideration should be
given to seek predisposing bleeding factors in order to assess the risk for neurological complications.
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Learning points
• Catheter ablation has a growing role in the management of patients with atrial fibrillation and a growing number of patients with multiple
comorbidities are being treated. These are fragile patients and may present high bleeding risk.
• Post-pulmonary vein isolation neurological complications are very rare events and potentially life-threatening.
• Spinal cord bleeding can have insidious and misleading presentation with fluctuating central or peripheral neurological symptoms.
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Introduction
Pulmonary vein isolation (PVI) is becoming the therapy of choice for
symptomatic paroxysmal drug-refractory atrial fibrillation (AF). The
most frequently reported complications are vascular complications
(1.4%) in a setting of overall low complication rate (<2.9%).3 Bleeding
complications of the central nervous system (CNS) have rarely been
described. We report a case of spontaneous spinal bleeding after PVI
not reported in the literature so far.
Timeline
Case presentation
A 68-year-old woman with a 2-year history of highly symptomatic
drug-refractory paroxysmal AF (EHRA 3), previously treated with a
previous PVI procedure, was referred to our division for a PVI redo
procedure. The patient (height 160 cm, weight 69 kg) presented a his-
tory of two-vessel coronary artery disease treated with percutan-
eous revascularization, a CHA2DS2-VASc score of 4, and HAS-BLED
score of 2. She had a history of hypertension, hypothyroidism, and a
congenital ostium secundum atrial septal defect with a left-right spon-
taneous shunt. The patient presented also moderate kyphoscoliosis
of the vertebral column, most prominent at the lumbar level. She was
treated with rivaroxaban 20 mg/day, aspirin, sotalol, thyroxin, fur-
osemide/spironolactone medication, and pantoprazole. The pre-
procedural blood values, including routine coagulation indices were
all normal.
The anticoagulation therapy was interrupted 36 h before the pro-
cedure and a transoesophageal echocardiogram performed on the
same day of the procedure excluded left atrial appendage thrombi.
The procedure was performed under general anaesthesia and vascu-
lar access was obtained through the right femoral vein. High-density
mapping was performed during sinus rhythm and showed pulmonary
vein reconnection of all pulmonary veins. A radiofrequency ablation
catheter (Thermocool Smarttouch, Inc., Irvine, CA, USA) was per-
formed; it showed a reconnection of three pulmonary veins. A map-
ping procedure obtained 20 min after the last ablation point showed
a persistent deconnection of all pulmonary veins. Atrial programmed
stimulation as well as repeated high-rate pacing bursts did not induce
AF. During the entire procedure, the patient had a sinus rhythm,
remained stable with vital signs within range of normality; ACT was
stable around 300 s with a final procedural value of 259 s. No rever-
sion of anticoagulation was performed and no intraprocedural and
peri-procedural complications occurred. The patient was then care-
fully transferred to the ward bed with the aid of a sliding mat; a man-
datory 4 h bed rest and immobilization was prescribed.
At the time of femoral vein haemostasis (4 h after PVI completion),
the ACT was 110 s; rivaroxaban (20 mg) was then administered. In
the following hours, the patient developed right gluteal and bilateral
lumbar pain, right lower limb paraesthesia, and motor deficits below
the knee [patellar and achillean hyporeflexia; iliopsoas, quadriceps,
ankle dorsiflexors, plantar flexors, and long toe extensors motor defi-
cits (MMT 2)]. A psoas sign was also present. The neurological symp-
toms fluctuated presenting an on–off pattern intermittently affecting
either the right or left lower limb; there was the suspicion for either a
transient central or peripheral involvement. A complete thoracic,
chest, and cerebral angio-computed tomography scan was per-
formed and acute retroperitoneal or cerebral bleeding were
excluded.
Furthermore, a cervical, dorsal, and lumbar native magnetic reson-
ance imaging was then performed. This examination showed a sub-
dural spinal haematic collection with an associated epidural
component from L3 to S2 (8 11 mm in the axial plane, see Figure 1;
65 11 mm in the sagittal plane, see Figure 2). The subdural spinal
haematoma exerted compression over the dural sheath, abolishing
the liquoral representation around the cauda equina lateral right
nerve roots within L3–L4 and L4–L5 and within L5–S1 mainly in the
posterior bilateral location.
After consultation with neurologists and neurosurgeons, a ‘wait-
and-see’ treatment approach by withholding anticoagulation therapy
and patient immobilization was taken. Indeed, the operative risk of
subsequent lower limb paralysis associated to the surgical approach
was estimated too high and exceeding possible benefit. In the follow-
ing 9 days, a neurological rehabilitation and sub-therapeutic anticoa-
gulation regimen was initiated. There was progressive recovery of
sensorial and motor deficits. After 5 months though, the patient still
presented residual lower limb motor deficits necessitating the sup-
port of a walking stick.
Discussion
To our knowledge, this is the first case of spontaneous spinal sub-
dural bleeding observed after a PVI procedure.
.................................................................................................
Timeline Events
7 months before
presentation
First pulmonary vein isolation (PVI) procedure.
3 months before
presentation
New severely symptomatic atrial fibrillation
episodes.
Day 1 PVI redo procedure performed.
4 h later Restarting oral anticoagulation (Rivaroxaban).
6–9 h later Beginning of neurological fluctuating deficits.
Thoracic, chest, and cerebral angio-com-
puted tomography scan was performed.
12 h later Worsening symptoms. A cervical, dorsal and
lumbar native magnetic resonance imaging
was performed with evidence of subdural
spinal haematic collection with an associated
epidural component from L3 to S2.
24 h later Elevated surgical risk. Conservative approach.
Day 6 Clinical stability with minimal improvement.
Day 9 Discharge from cardiology department to
neurological rehabilitation centre.
5 months after
discharge
Still minor sensorial and motor deficits. Need
of a walking stick.
2 G.M. Cioffi et al.
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Although this complication has never been reported following PVI,
it emphasizes the need of careful evaluation of multimorbidity
patients and of possible muscle-skeletal changes beyond the patholo-
gies included in the HAS-BLED score.
Oral anticoagulation was interrupted 36 h before the procedure;
this was in agreement with the 2017 HRS/EHRA/APHRS/SOLAECE
recommendations12, when the procedure was performed.
Subsequently, recommendations by scientific societies13 changed
into uninterrupted DOACs at the time of PVI. Although speculative,
during uninterrupted DOACs (in cases when CHA2DS2-VASc >_3,
availability of cardiac imaging assessment at procedural time) or inter-
rupted within 12–24 h, the bleeding risk in a patient could even be
higher than that assessed by the HAS-BLED score. Indeed, anatomic
conditions may increase the bleeding risk and are not part of the
HAS-BLED score.
Vascular complications are the most frequent procedure-related
adverse events following PVI procedure. These include generic
haematoma of the groin, retroperitoneal haematoma, pseudoaneur-
ysm, arteriovenous fistula, and hemothorax (subclavian or internal
jugular venous access) with an incidence in the range of 1–2%3. Peri-
procedure anticoagulation regimen seems to be an important factor
in the occurrence of these complications.
Intracranial severe spontaneous bleeding complications are rare
after PVI (incidence of 0.31). However, as described in the present
case, such complications may cause invalidating and irreversible body
injury which may be particularly limitative in more compromised
patients. As observed in the present case, even careful procedural
planning with guidelines recommendations of peri-procedural antico-
agulation management did not prevent a severe CNS bleeding ad-
verse event.2–3
Spinal cord bleeding is a unique condition with significant disabling
consequences. It is classified based on the primary location of
bleeding into intramedullary (haematomyelia), subarachnoid haemor-
rhage (SAH), subdural haemorrhage, and epidural haemorrhage. It
requires emergency investigation and treatment.4–6 Based on the
existing literature spinal vascular malformations such as intradural ar-
teriovenous malformations are the most common cause of atraumat-
ic intramedullary spinal cord haemorrhage. Additional causative
factors include warfarin or heparin anticoagulation, hereditary or
acquired bleeding disorders, primary spinal cord tumours, spinal cord
metastases, or a delayed complication of spinal radiation7–11.
Onset may vary with sudden, severe back or neck pain and some-
times radicular or with rapidly progressive flaccid quadri/biparesis,
with subsequent ventilatory failure reported in cases where bleeding
involves the cervical and superior dorsal spine. Magnetic resonance
imaging with and without gadolinium is the gold standard neurological
imaging modality. There are no clinical trials to guide the management
of acute intramedullary spinal cord haemorrhage, and subsequent
treatment is usually directed towards the underlying cause. Early
surgical treatment is always indicated when the patient’s neurological
status progressively deteriorates with severe central complications
(such as ventilatory failure) but also conservative treatment is
possible, whenever neurological impairment is minimal and self-
limiting.
Conclusion
In conclusion, for the first time spinal subdural bleeding after PVI is
reported. Careful peri-procedural management of anticoagulation
therapy as well as assessment of patient bleeding risk are mandatory.
Little is known on the predisposing factors that could identify which
patients may be at risk of bleeding complications such as that
reported in this case.
Figure 1 Subdural spinal haematic collection 8 x 11 mm, axial
plane.
Figure 2 Subdural spinal haematic collection 65 x 11 mm, sagittal
plane.
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